Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol

[1]  M. Federico,et al.  FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  G. H. Jackson,et al.  Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology , 2015, British journal of haematology.

[3]  J. Mehta,et al.  Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project , 2015, Drug Safety.

[4]  H. Iwasaki,et al.  Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study. , 2014, Anticancer research.

[5]  Y. Hasegawa,et al.  Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome , 2014, SpringerPlus.

[6]  M. Lopez‐Olivo,et al.  Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  R. Day,et al.  Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012 , 2013, Drug Safety.

[8]  Yan Ge,et al.  Generalized multidimensional dynamic allocation method , 2012, Statistics in medicine.

[9]  B. Coiffier,et al.  Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus , 2010, British journal of haematology.

[10]  C. Pui,et al.  Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.